| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a6593d17e5fe557301f9dede583b574 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-245 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245 |
| filingDate |
2021-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67d3a9e8e2d7b30d15372448d45882bd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_444f2a8575897670a2c42cbf95ea70ce |
| publicationDate |
2021-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2021198504-A1 |
| titleOfInvention |
Active substances for medical use |
| abstract |
The present invention relates to an amine (AM) according to general formula (I); a carboxylic acid adduct (KA) and a pharmaceutical composition (PZ) for use in the treatment of atypical pneumonia and for use in the therapy of viral diseases. |
| priorityDate |
2020-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |